Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.

Telehealth study of patient portal e-visits by Medicare participants shows few had an interaction for which their provider billed them.

An updated rat reference provides more accuracy for research; could help researchers using rat models for the study of DNA, RNA, evolution, or genes linked to disease risks

The new Epigenomic Metabolic Medicine center (EM2C) will contribute to understanding how genetic variations contribute to common, complex diseases such as diabetes

New website to help adolescents with disabilities learn about reproductive health.

Lung disease specialist comes to Michigan from Vanderbilt University School of Medicine to lead largest department

Cases of kidney stones in children are increasing, but parents can minimize the chances their kids develop them.

A large study shows having bipolar disorder is associated with a four- to six-fold risk of dying prematurely, suggesting more preventive efforts needed. Visit Health Lab to read the full story.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

A Michigan Medicine urogynecologist discusses what urinary tract infections are, how they are treated and what new research is on the horizon.

For people with expensive prescription drugs, switching plans could save them thousands of dollars in copays. And a simple tool can help people easily compare out-of-pockets expenses for anyone with a Medicare Part D prescription plan.

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.